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SUMMARY
The aim of this study was to evaluate the epidemiological, clinical and laboratorial profile of patients with Baggio-Yoshinari 
Syndrome (BYS), who underwent internment at the Instituto de Infectologia Emilio Ribas in São Paulo, Brazil, during the period 
from July 1990 to July 2006. BYS is a new Brazilian tick-borne disease caused by Borrelia burgdorferi sensu lato microorganisms 
that resembles features of Lyme disease (LD), except for its epidemiological, clinical and laboratorial particularities. From 60 patients’ 
records with positive serology to B. burgdorferi done by ELISA and Western-blotting methods, 19 cases were diagnosed as having 
BYS, according to criteria adopted at LIM-17 HCFMUSP, the Brazilian Reference Laboratory for the research of BYS. The other 41 
remaining patients displayed miscellaneous infections or auto-immune processes. The beginning of symptoms in BYS group varied 
from one day to six years, from the onset of the disease. Four of 19 patients were included in acute disease stage, and 15 in latent. 
General unspecific symptoms were identified in almost all cases, with high frequencies of fever (78.9%) and lymphadenomegaly 
(36.8%). Six patients had skin lesions (31.5%); six arthralgia or arthritis (31.5%) and eight neurological symptoms (42%). Interestingly, 
two patients showed antibodies directed to B. burgdorferi exclusively in cerebrospinal fluid. Since BYS is a new emergent Brazilian 
zoonosis and its diagnosis is sometimes complex, all the new knowledge about BYS must be scattered to Brazilian Medical specialists, 
aiming to teach them how to diagnose this amazing tick-borne disease and to avoid its progression to chronic irreversible sequels.
KEYWORDS: Lyme Disease; Lyme disease-like illness; Baggio-Yoshinari Syndrome; Tick-borne diseases; Borrelia burgdorferi; 
Brazil.
INTRODUCTION
Lyme Disease (LD) is a frequent zoonosis transmitted by Ixodes 
ricinus complex ticks, caused by Borrelia burgdorferi sensu lato 
complex microorganisms, constituted by at least 11 spirochete species. 
B. burgdorferi sensu stricto is identified in the United States of America 
(USA) and Eurasia, while B. afzelii and B. garinii in Europe and 
Asia2,8,36,37. Skin and joint symptoms are predominant in the USA, while 
neurological disorders are more frequent in Europe2,13,21.
A similar zoonosis called Lyme disease-like Illness or Masters’ 
Disease, also known as Southern Tick-Associated Rash Illness (STARI) 
has been reported in the south of USA27, caused by B. lonestari, which 
is a spirochete uncultivable in BSK medium and genetically similar to 
B. theileri, found in cattle. STARI is transmitted by the Amblyomma 
americanum tick, and the clinical picture is characterized by the 
appearance of erythema migrans (EM), without jeopardy of internal 
organs. Furthermore, patients with STARI do not develop antibodies to 
B. burgdorferi. 
The proposal of LD research in Brazil emerged in 1989, with the 
gathering of a multidisciplinary team39. The group intended to identify 
patients in Brazil and to perform microbiological and diagnostic tests. In 
1990, the Laboratório de Investigação em Reumatologia do Hospital das 
Clínicas da Faculdade de Medina da Universidade de São Paulo (LIM-
17 HCFMUSP) was considered by the Brazilian Health Department as 
Reference Laboratory to research and to assist suspected patients. 
In 1992, the first cases of Brazilian LD were described40, admitted to 
the Instituto de Infectologia ¨ Emilio Ribas¨ (IIER). These young patients 
presented fever, erythema migrans (EM) and arthritis, and the diagnosis 
was confirmed at the LIM-17 HCFMUSP Lab by ELISA and Western-
blotting (WB) assays, using B. burgdorferi sensu stricto antigens of North 
American origin, originally isolated from the tick Ixodes scapularis. 
Since then, many other cases were reported, all of them exhibiting similar 
clinical features of LD, including presence of EM and systemic articular, 
neurological and cardiac symptoms5,11,34,41,42,43,45,47.
However, along the years, many distinguishing features were 
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identified in Brazil. B. burgdorferi had never been isolated or cultured 
in BSK, even when many enriched media were employed to culture 
biological materials from patients12,38, potential reservoir animals1 or 
ticks collected at risk areas6.
Ticks from Ixodes ricinus complex, the main invertebrate hosts 
involved in Borrelia transmission in USA and Eurasia, had never been 
found biting people at risk areas. On the contrary, it was reported 
emergence of Brazilian LD in a laboratory researcher, accidentally bitten 
by Amblyomma cajennense tick (Yoshinari NH-personal communication). 
Ticks of genus Rhipicephalus were also suspected to transmit spirochetes, 
due to coexistence of antibodies to B. burgdorferi and Babesia bovis in 
Brazilian LD patients44.
Molecular Biology studies (PCR) performed by COSTA10 and 
BARROS4 using human and ticks samples revealed negative results, 
when primers to amplify conservative specific genes of B. burgdorferi 
were used. The primers employed were targeted to identify outer surface 
protein A (OspA)22 and genes for major flagellin FlaB and minor flagellin 
FlaA20, as well as for ribosomal 16S rRNA3.
Clinically, Brazilian LD-like patients present increased frequency 
of relapsing episodes, especially if the disease is unrecognized at an 
early stage or wrongly treated. Furthermore, in most of cases, antibiotic 
treatment is not efficient to cease recurrent disease symptoms. Allergic 
manifestations including acquired angioedema, have been also described 
along the disease progression17,42,45,47.
Laboratorial assays to diagnose Brazilian LD-like illness is a very 
complex question, since antibodies against B. burgdorferi sensu lato 
identified by ELISA or Western-blotting procedures offer low sensitivity 
and specificity42,47. In this respect, when both assays are employed together 
in Brazilian patients, the positivity reaches only 65% of cases, while in a 
normal control group the frequency is around 16%25. However, serological 
diagnostic procedure for LD diagnosis in USA based on two-tier algorithm 
using ELISA or IFA (immunofluorescence assay) as screening tests and WB 
as confirmatory assay is also considered inadequate for clinical purposes19. 
Another important laboratorial aspect in Brazil is the demonstration of 
autoimmune disorders, including the emergence of antinuclear antibodies 
(ANA), anticardiolipin, anti-neutrophil cytoplasmic antibodies (ANCA), 
and antineuronal antibodies in the blood of patients17,42.
MANTOVANI et al.24 had described structures resembling 
Mycoplasma spp, Chlamydia spp and long bacterium-like microorganisms 
in the peripheral blood of patients by electron microscopy analysis. Since 
serologic and PCR assays did not confirm presence of these latent 
bacteria, researchers from LIM-17 HCFMUSP proposed that etiological 
agent found in Brazil could be expressed at atypical morphologies46.
MANTOVANI26 in her PhD thesis, presented to Faculdade de 
Medicina da Universidade de São Paulo, identified the etiological agent 
as spirochete belonging to B. burgdorferi sensu lato complex, executing 
a PCR assay, employing a conserved gene that synthesizes the flagellar 
hook (flgE)30 (unpublished data). Other preliminary unpublished results 
also showed that ticks from genus Rhipicephalus and domestic animals 
like horses and bovines were infected by microorganisms and can 
participate in the epidemiological process of this emergent Brazilian 
tick borne disease.
Due to these many particularities, this tick-borne zoonosis found in 
Brazil, was assumed to be an exotic infectious disease, and thus, in an 
attempt to distinguish it from classical LD was named Baggio-Yoshinari 
Syndrome (BYS)16. Currently, BYS is defined as a new Brazilian tick-
borne disease that imitates clinical and laboratorial features of LD, 
caused by B. burgdorferi sensu lato spirochete, possibly at its atypical 
morphologies and being transmitted by ticks of genus Rhipicephalus and 
Amblyomma, thus not belonging to Ixodes ricinus complex.
We assume that Brazilian biodiversity and distinct geographic 
conditions, especially the occurrence of exotic tick species and animal 
reservoirs, originated mutant B. burgdorferi adapted to survive in the 
country. Mutant Borrelias with genetic changes at its different genes 
has been previously described by MALAWISTA et al.23, SADZIENE et 
al.31,32,33, FINGERLE et al.14, MOTALEB et al.28, CHARON et al.9. The 
existence of mutant spirochete expressed at atypical cystic morphologies, 
possibly without periplasmic flagella and decreased expression of outer 
surface proteins (Osp), justify all the particularities found in BYS. 
Due to existence of many distinguishing features in BYS, most of 
them never described before, it is easy to understand the difficulties found 
by Brazilian physicians to diagnose this new zoonosis. In fact, it is not 
an easy task due to the occurrence of many pitfalls during BYS patients’ 
examination. Additionally, we have to understand that this emergent 
zoonosis is a specific Brazilian health problem and we cannot import 
answers from countries where LD exists. 
Our researchers point out that B. burgdorferi can originate two 
distinct diseases: LD and BYS, possibly according to geographical and 
biodiversity conditions. Interestingly, B. burgdorferi had never been 
identified in South America before, and even in the Southern hemisphere, 
suggesting the existence of many unanswered questions concerning the 
relationship between spirochetes, ticks, reservoir animals and ecological 
conditions. In this respect, we postulate that this complex relationship 
is associated to emergence of different B. burgdorferi mutants, which 
in turn, causes distinguishing clinical and laboratorial manifestations.
The aim of this study was to characterize the epidemiological, clinical 
and laboratorial profile of BYS patients, admitted to the IIER, which is 
a reference hospital for infectious diseases. The frequency of BYS is 
growing fast, and as we said before, we have to produce new knowledge 
to answer many unsolved questions concerning this emergent zoonosis. 
In this respect, we intend to discuss practical medical questions emerged 
after analyzing the casuistic of BYS admitted to IIER, aiming to help 
physicians to deal with this original and amazing infectious disease. 
MATERIALS AND METHODS
From July 1990 to July 2006, the IIER sent 171 serum and/or CSF 
samples with suspicion of BYS to LIM-17 HCFMUSP Lab, to perform 
serological tests for B. burgdorferi, through the Indirect immunosorbent 
assay (ELISA)29 and a modified Western Blotting (WB)18,40. 
The diagnosis of BYS was based on the previously described 
criteria24, with final exclusion of infectious diseases and auto immune 
disorders that could lead to false-positive serology. 
From the 171 sera or CSF samples submitted to antibody research, it 
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was possible to recover and to analyze 60 patient records. After exclusion 
of specific infectious or autoimmune diseases, 19 patients (31.6%) 
fulfilled diagnostic criteria and remained with final diagnosis of BYS. In 
this subgroup of patients, the following aspects were examined: gender, 
age, origin, tick bite or positive epidemiology, city and state where the 
infection probably was acquired, and clinical profile. 
RESULTS
Characterization of 60 patients with positive serology to B. 
burgdorferi: Description of the group of 60 patients with positive 
serology to B. burgdorferi is detailed in Table 1. Nineteen patients 
remained as BYS (31.6%) and 41 patients (68.4%) were diagnosed as 
having other diseases. 
The following diseases had false positive serology for B. burgdorferi: 
rheumatic or autoimmune diseases (n = 11; 18.3%); leptospirosis (n = 
4; 6.6%); dengue fever (n = 2; 3.3%); tuberculous meningoencephalitis 
(n = 2; 3.3%) and miscellaneous diseases (one patient/each disease), 
including Brazilian Spotted Fever, HIV, salmonellosis, meningococcemia, 
pneumococcal meningitis, Toxocara canis meningitis, herpes virus 
meningitis, meningitis associated to mastoiditis and tropical pyomyositis. 
Twelve patients (20%) remained undiagnosed.
Clinical and epidemiological profile of the 19 patients with final 
diagnosis of BYS: From the 19 individuals with final diagnosis of BYS, 
53% were women and 47% men, and the mean age was 26 years (4 to 
68 years). Four patients were identified at acute disease stage (until three 
months from disease onset) and fifteen at latent phase. 
Regarding the patients origin, thirteen were living in São Paulo city, 
two came from São Bernardo do Campo, and the other four were from 
Cotia, Guarulhos, Pirapora do Bom Jesus and Juquitiba, all municipalities 
belonging to the São Paulo State. 
In only five out of 19 patients (25%), it was possible to determine the 
exact region where the infection was acquired: the urban area of São Paulo 
city (two patients), Juquitiba, Cotia and the region around Billings dam.
Signs and symptoms of 19 patients with BYS: The meantime 
between the tick bite episode and the appearance of first symptoms varied 
from one day to six years. General “flu-like” symptoms were observed in 
15 patients (78.9%). Fever was the most frequent symptom, viewed in 11 
cases (57.8%), isolate or multiple lymphadenomegaly was found in seven 
patients (36.8%) and headache was the third most common symptom, 
followed by the presence of chills, vomit, odynophagia, diarrhea, cough, 
hyperhidrosis, and conjuctival hyperaemia (Fig. 1). 
Six patients (31.5%) had skin lesions. Itching acute erythema migrans 
was observed in one case (5.2%), annular secondary erythema in three 
cases (15.7%) and petechiae-like lesions in two cases (10.5%).
Regarding the disorders of the locomotor apparatus, six patients 
(31.5%) presented arthralgia or arthritis, and six patients (31.5%) had 
myalgia. 
Eight patients (42%) presented neurological disorders. Meningitis 
was the most common finding, observed in five cases (26.3%). It was an 
isolated symptom in only one patient, three cases had meningoencephalitis 
and the fifth patient was associated to cranial and peripheral neuritis. Four 
patients unrolled isolate or multiple cranial neuritis with symptoms of 
dysarthria, diplopia, facial nerve palsy, eye lid ptosis, etc. Four patients 
had peripheral sensitive and/or motor neuropathy. Seven out of eight 
patients presented multiple neurological manifestations (Table 2), which 
is a prominent feature of neurological involvement related to BYS. 
Laboratorial findings of 19 patients with BYS: All studied patients 
presented antibodies against B. burgdorferi. Two cases had antibodies 
detected by ELISA only in the cerebrospinal fluid (CSF). Among another 
Table 1
Final diagnosis of the 60 patients with positive serology to B. burgdorferi 
admitted at IIER
Final Diagnosis N (%)
BYS 19 (31.6%)
Rheumatic and/or auto immune disease 11 (18.3%)
Leptospirosis 4 (6.6%)
Dengue 2 (3.3%)
Tuberculosis meningoencephalitis 2 (3.3%)




Pneumococcal meningitis 1 (1.6%)
Toxocara canis meningitis 1 (1.6%)
Herpes virus meningoencephalitis 1 (1.6%)
Meningitis secondary to mastoiditis 1 (1.6%)
Epidural empyema 1 (1.6%)
Tropical pyomyositis with osteomyelitis 1 (1.6%)
Other causes 12 (20.0%)
Total 60 (100%)
Fig. 1 - List of general symptoms presented by the 19 patients with Baggio-Yoshinari 
syndrome admitted to IIER.
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17 cases, nine (52.9%) had antibody identified by WB to B. burgdorferi, 
five (29.4%) by ELISA, and only three patients (17.5%) demonstrated 
antibodies by WB and ELISA assays at the same time.
Eleven out of 19 patients had the cerebrospinal fluid (CSF) 
analysis performed. Six samples exhibited a discreet increase 
of lymphomononuclear cells (less than 200 cells/mL) and seven 
showed higher CSF protein concentration. Isolated increased protein 
concentration was demonstrated in one case.
Other laboratorial exams were conducted with all samples to 
exclude infectious or autoimmune diseases. Haemogram was normal in 
all cases. Six patients performed VDRL test (CSF and/or blood), three 
were submitted to serologic analysis for rickettsiosis, four patients for 
brucellosis, three patients for typhoid fever and five to anti-HIV test. 
These and other specific exams were negative. 
One patient with BYS had positive ANA with homogenous pattern 
(> 1/200) and another case presented positive anti-smooth muscle and 
anti-peroxidase antibodies. These data did not nullify diagnosis of BYS, 
since this syndrome can present autoimmune features. 
Treatment of the 19 patients with BYS: Fifteen of 19 patients were 
treated with antibiotics and the mean period of treatment time was 22 days, 
ranging from seven to 46 days. In four cases there was no information 
concerning a therapeutic scheme on the patients’ records. The antibiotics of 
choice were: ceftriaxone (42%), amoxicillin (16%), ceftriaxone associated 
with doxycycline (11%), erythromycin and tetracycline (5%).
DISCUSSION
After careful epidemiological, clinical and laboratorial analysis, 19 
out 60 (32%) patients with positive serology to B. burgdorferi, admitted 
at IIER remained with final diagnosis of BYS. The remaining 41 patients 
(68%) were identified as having autoimmune disease (N = 11; 18.3%), 
miscellaneous specific infectious diseases (N = 18; 30%) and the other 12 
patients (20%) stayed undiagnosed. In other words, this original research 
is very important for Brazilian physicians, since for the first time it was 
possible to estimate that 32% of BYS suspected patients with positive 
serology for B. burgdorferi displayed final diagnosis of BYS.
As reported before, serology for B. burgdorferi must be interpreted 
carefully, since it cross reacts with autoimmune and other infectious 
diseases42. Among these diseases we have rheumatoid arthritis, 
scleroderma, systemic lupus erythematosus, syphilis, leptospirosis, 
leishmaniasis, tuberculosis, acute virosis, etc. This manuscript also 
contributed to add a new list of infectious diseases that cross-react 
with BYS as dengue, Brazilian spotted fever, HIV, salmonellosis, 
meningococcemia, Toxocara canis meningitis, tropical pyomyositis, etc. 
The main learning of this article is to understand that BYS is 
an infectious disease of increasing interest for Brazilian physicians. 
However, since its diagnosis is very complex and difficult, the Brazilian 
physician must be well prepared to recognize it. Certainly, it is not an 
easy task, mainly at current days, when patient anamnesis is done quickly 
and often, replaced by expensive complementary subsidiary exams. 
It is important to note that only four out of 19 cases were at acute 
disease stage, when the patients still remembered recent epidemiological 
and clinical data as those symptoms related to tick bite history or visits to 
at risk areas. On the contrary, it is easy to understand how difficult was 
to diagnose the remaining 15 BYS patients belonging to latent disease 
stage, who underwent BYS symptoms after months or years from acute 
disease onset.
Clinically, BYS, different to LD, is recognized at acute and latent 
relapsing stage. The diagnosis and treatment of BYS at early stage is 
of critical relevance to avoid zoonosis progression to latent stage, when 
the disease can reveal irreversible sequels. Nowadays, it is shown that 
misdiagnosed or wrongly treated patients at acute disease stage in the past, 
can progress to chronic idiopathic rheumatic or neurological diseases. 
Unfortunately, the Brazilian Government does not consider acute stage of 
BYS of compulsory notification, since it does not kill people at this phase. 
Conversely, the economic costs to treat sequels of relapsing symptoms 
from latent stage are enormous.
Brazilian patients present the typical EM at tick bite site in nearly 
50% of cases. Few cases from this article had EM, possibly because 
clinical data was gathered retrospectively, and as we said before, patients 
from latent stage do not inform spontaneously earlier symptoms, and 
physicians during the anamnesis are not trained to inquire about EM 
or annular secondary lesions happened at a remote date. Articular and 
Table 2
Description of the nervous system disorders found in 19 patients with BYS admitted to the IIER
Case CNS Peripheral Nervous System
1  Patellar reflex asymmetry and walk difficulty
2 Meningoencephalitis, ataxia Dysarthria
3 Meningoencephalitis Diplopia
4  Shoulders and legs weakness, walk difficulty, hypoesthesia trembling
5 Meningoencephalitis Right central facial nerve paralysis, muscular weakness level IV of left leg and level III of right arm
6  Right peripheral facial nerve paralysis, walk difficulty, muscular weakness of the legs, paresthesia in boots 
and gloves
7 Meningitis Left eyelid ptosis, fixed mydriasis, dysarthria, weakness of right leg strength level IV
8 Meningitis
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neurological symptoms occur in nearly 35% of BYS patients and similar 
frequencies were observed in the present study. 
Importantly, patients from the present research exhibited the same 
pattern of neurological involvement reported in previous manuscripts, 
as the predominance of meningitis, isolated or associated to peripheral 
or facial neuritis. One of the hallmark features of BYS is the occurrence 
of simultaneous multiple neurological involvement or its association 
with arthritis, identified in nearly 50% of patients. Furthermore, the 
frequencies of typical recurrent annular secondary skin lesions and ¨ flu-
like symptoms¨ decrease as the disease progresses, bringing additional 
difficulties to identify latent BYS34.
Currently, many other minor or major symptoms are considered useful 
to diagnose BYS. Patients with BYS display many subjective symptoms 
as those related to chronic fatigue, fibromyalgia, cognitive disturbance or 
emotional, labor and social disabilities. Additionally, these patients can 
mention present or past relevant psychiatric complaints (depression, panic 
syndrome, schizophrenia-like, suicidal attempt), cardiac (arrhythmias, 
cardiomegaly) or ocular symptoms (uveitis, optic neuritis, retinal arteritis, 
papilledema)47. Also, skin lesions are not restricted to the presence of 
EM or annular secondary lesion. Localized scleroderma-like lesion, 
benign B lymphocytoma, acrodermatitis chronica atrophicans (ACA) and 
panniculitis have been described in Brazil15,47. All these symptoms already 
identified in BYS, must be remembered by Brazilian physicians when 
they are performing a patient’s anamnesis and physical examination. 
Other important learning of this manuscript is to accept that isolated 
detection of antibodies to B. burgdorferi is not diagnostic for BYS. 
Indeed, we saw that two thirds of patients with positive serology had 
autoimmune or other infectious diseases. Also, negative serology for 
identification of B. burgdorferi infection does not rule out the hypothesis 
of this tick borne zoonosis, since sensibility of both specific assays 
together (ELISA plus WB) is low, approximately 65%. Despite all the 
difficulties, the serology for search of B. burdorferi infection is still an 
important diagnostic parameter if interpreted carefully, always conjugated 
to careful anamnesis and physical examinations. 
Sometimes, mainly at acute disease stage, the serological results are 
unnecessary, especially if the patient became ill after tick bite history 
and presented EM. Similarly, the emergence of arthritis or neurological 
symptoms after weeks or months following the disease onset, must be 
related to BYS and deserve specific treatment, even when antibodies to 
B. burgdorferi are absent. It is important to note that antibody titers in 
the sera of BYS patients are low and oscillating, possibly because we 
have used antigens of North American origin. Also, as commented before, 
B. burgdorferi was never cultured or isolated in Brazil. Additionally, 
Brazilian etiological agent seems to be expressed at cystic form with 
suppression/inhibition of many genes and proteins, explaining the low 
repertoire of antibodies to B. burgdorferi confirmed by WB analysis. 
All these features indicate that Brazilian B. burgdorferi is a spirochete 
which is very well adapted to survive in vertebrate and invertebrate hosts, 
justifying occurrence of relapsing symptoms. 
Searching for antibodies to B. burgdorferi in CSF is a good diagnostic 
option, mainly if we are dealing with a neurologic patient with previous 
negative serology for B. burgdorferi done in the serum. Two of 16 
patients of this study had antibodies exclusively in CSF. Interestingly, 
according to our unpublished experience, cerebrospinal fluid from normal 
individuals, mostly with headache, does not reveal antibodies against B. 
burgdorferi. Unfortunately, the finding of antibodies to B. burgdorferi 
in CSF is equally unspecific, since cross-reactivity happens with many 
neurological infections like syphilis, tuberculosis, herpes virus, HIV, 
HTLV, etc (unpublished data).
The question concerning autoimmunity in BYS deserves further 
comments. Often, patients with BYS exhibit symptoms present in 
rheumatic diseases like fever, arthritis, myalgia, muscle weakness, 
Raynaud´s phenomenon, sicca syndrome complaints, vasculitis, 
photosensibility, neuritis, meningitis, ocular manifestations, skin 
rashes, etc. Also, laboratorial findings can mimicry autoimmune 
disorders by appearance of ANA, anti cardiolipin antibodies, 
antineutrophil cytoplasmic antibodies (ANCA), antitireoperoxidase 
antibodies, hypergammaglobulinemia, anti neuronal antibodies, etc. 
For these reasons, physicians must be aware to distinguish BYS from 
autoimmnune diseases. Additionally, we have found anemia, leucopenia, 
thrombocytopenia, transaminases increase and bilirrubinemia, mainly in 
BYS patients suspected of co-infections with other tick-borne diseases 
like babesiosis, ehrlichiosis, bartonellosis and rickettsiosis7,35.
We assume that the frequency of BYS at the IIER in the studied 
period is higher than demonstrated in this manuscript. First of all, we 
excluded patients with symptoms of BYS without positive serology for 
B. burgdorferi, even when autoimnune or other infections were ruled 
out. Also, it is plausible to admit that among the 12 undiagnosed patients 
(20%) with positive serology for B. burgdorferi, without autoimmune or 
other specific infection, a new careful anamnesis of the past history or 
follow up looking for eventual relapsing symptoms in the future, could 
contribute to an increase in the frequency of BYS positivity. 
A few number of patients offered safe information about where 
they were infected. It was not a surprise that two patients acquired the 
disease inside the urban area of São Paulo, because many peripheral 
urban regions exhibit rich vegetation with presence of wild and domestic 
animals. Previous reports had already demonstrated BYS onset, within 
São Paulo city, showing that this zoonosis is also a cosmopolitan 
disease42,43. Recently, we have performed PCR for B. burgdorferi using 
flgE primer and preliminary unpublished results confirmed that bovines 
and horses participate in the BYS transmission (unpublished data). Also 
B. burgdorferi has been identified in ticks from genus Rhipicephalus, 
which infest these domestic animals (unpublished data). These reports 
confirm that epidemiology of BYS is very different from those observed 
in LD, explaining why the zoonosis behavior is so different in our country.
In general, people are infected casually at small rural municipalities 
around São Paulo city or in forested areas close to the beaches. It is 
important to know that premature tick removal from the skin before 24 
hours avoids spirochete transmission. People must wear clear clothes, 
boots, tick repellents and search carefully for ticks after visiting at risk 
areas. 
As far as the treatment is concerned, 15 out of 19 patients with BYS 
were submitted to antibiotic therapy, most of the cases with ceftriaxone 
2g/day, given over an average of 22 days. Unfortunately, it was not 
possible to obtain additional information about the other four patients’ 
records, neither about the evolution of the patients treated with antibiotics. 
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Currently, acute cases of BYS are treated with doxycycline 100 mg 
b.i.d. or amoxicillin, 500 mg each q.i.d for 30 days. Relapsing symptoms 
are treated with ceftriaxone, 2 g a/day for 30 days with additional use 
of doxycycline 100 mg twice a day for three months or continuous use 
of doxycycline for four months. In general, ceftriaxone or penicillin 20 
millions/day/IV are indicated when neurological symptoms are present. 
Hydroxychloroquine 400 mg/day given for a prolonged period of time 
seems to be a useful drug to avoid appearance of recurrent symptoms. 
Unfortunately, we are not sure about the real role and importance of 
antibiotic treatment at latent stage of BYS, because autoimmune disorders 
are equally observed at this disease stage. Otherwise, spirochetes have 
been identified by PCR procedure in some patients with BYS at latent 
stage, after years from disease onset. Surprisingly, in some cases, patients 
reported previous treatment with antibiotics (unpublished data).
The prevalence of BYS in Brazil is unknown, but the number of 
suspect cases is growing fast, since physicians of different specialties 
are starting to recognize this new tick-borne disease. However, it has 
been a very difficult task to spread knowledge on BYS, because medical 
students are accustomed to learn about LD in International Medical 
Textbooks, and we know that this North American and Eurasian zoonosis 
is completely different. The achievement of knowledge on BYS has been 
done slowly due to its complexity. We believe that this manuscript can 
be very helpful for Brazilian physicians, in helping them avoid pitfalls 
usually found in BYS patients.
Unfortunately, often we are censured by external referees since 
we cite our own articles. However, we have to understand that this is a 
necessary procedure since we are dealing with a new Brazilian infectious 
disease and we need to develop our own learning, instead of bringing 
knowledge from foreign countries. 
BYS must receive great attention from Public Health managers 
due to its high morbidity and propensity to cause irreversible sequels. 
Researches and results on BYS have been an enormous scientific 
challenge, which demand extensive cooperation with experts of 
different areas, in an attempt to full disclosure this intriguing Brazilian 
tick borne zoonosis. Finally, it has not been an easy mission to assume 
responsibilities to research and to transmit knowledge of this unbelievable 
disease, mainly because it involves deep conceptual changes concerning 
host versus microorganism relationship.
RESUMO
Perfil dos pacientes com Síndrome Baggio-Yoshinari admitidos no 
“Instituto de Infectologia Emilio Ribas¨
O objetivo do estudo foi avaliar o perfil epidemiológico, clínico 
e laboratorial dos pacientes com Síndrome Baggio-Yoshinari (SBY), 
internados no Instituto de Infectologia Emilio Ribas, São Paulo, Brasil, 
no período de julho de 1990 a julho de 2006.  SBY é uma nova doença 
transmitida por carrapatos, causada pela Borrelia burgdorferi sensu lato, 
que se assemelha a Doença de Lyme (DL), exceto pelas particularidades 
epidemiológicas, clínicas e laboratoriais.  A partir dos registros de 60 
pacientes com sorologia positiva para B. burgdorferi pelos métodos de 
ELISA e Western-blotting, 19 casos foram diagnosticados como SBY, 
de acordo com critérios adotados pelo LIM-17 HCFMUSP, laboratório 
de referência para a pesquisa de SBY no Brasil.  Os outros 41 pacientes 
restantes foram classificados como tendo infecções diversas ou processos 
auto-imunes.  O início dos sintomas no grupo SBY variou de um dia a seis 
anos.  Quatro dos 19 pacientes foram incluídos na fase aguda da doença e 
15 na fase latente.  Os sintomas gerais inespecíficos foram identificados 
em quase todos os casos, com altas freqüências de febre (78,9%) e 
linfoadenomegalia (36,8%).  Seis pacientes tiveram lesões de pele 
(31,5%); seis artralgia ou artrite (31,5%) e oito sintomas neurológicos 
(42%).  Curiosamente, dois pacientes apresentaram anticorpos para 
B. burgdorferi exclusivamente no líquido cefalorraquidiano.  Uma vez 
que a SBY é uma zoonose emergente brasileira e seu diagnóstico é 
complexo, todo o conhecimento novo sobre SBY deve ser difundido 
para os médicos brasileiros, com o objetivo de ensiná-los a diagnosticar 
esta surpreendente doença transmitida por carrapatos, evitando-se a sua 
progressão para sequelas crônicas irreversíveis.
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